Paul E. Solís-Hidalgo, Servicio de Coloproctología, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Gerardo J. Maya-Vacío, Servicio de Coloproctología, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Jeziel Ordóñez-Juárez, Jefatura del Servicio de Coloproctología, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jal., México
Billy Jiménez-Bobadilla, Jefatura del Servicio de Coloproctología, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Jorge L. de León-Rendón, Clínica de Enfermedad Inflamatoria Intestinal, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Jorge Garza-Sánchez, Servicio de Coloproctología, Hospital Ángeles Puebla, Puebla, Pue., México
Mónica P. Hernández-Molina, División de Cirugía Oncológica, ISSSTEP, Puebla, Puebla, México
Juan A. Villanueva-Herrero, Unidad de Fisiología Anorrectal, Servicio de Coloproctología, Hospital General de México Dr. Eduardo Liceaga, Ciudad de México, México
Carlos A. López-Bernal, Subdirección de Cirugía, Hospital de Especialidades del Centro Médico Nacional Manuel Ávila Camacho, IMSS, Puebla, Puebla, México
Objective: To demonstrate the relationship between the neutrophil/lymphocyte ratio (NLR) and the recurrence of anal lesions caused by the human papillomavirus (HPV). Method: A retrospective study was conducted with 60 patients who underwent resection of anal lesions caused by HPV. The NLR was recorded prior to surgery and the cut-off point for patients who presented recurrence of the lesions was determined using a ROC curve. Results: Lower values were found in those who presented recurrence of the disease. It was shown that an NLR less than 1.84 is associated with a higher risk of recurrence, of 3.800 with a 95% CI (1.632-8.848). Conclusions: The NLR is a useful and easily reproducible tool for the follow-up of patients who underwent resection of anal lesions due to HPV; obtaining a low value is related to a higher risk of recurrence.
Keywords: HPV. NLR. Recurrence.
